Taiwan’s president unveiled the country’s combat wing of advanced US-made F-16 fighters in a ceremony on Thursday, showing its new Air Force capabilities against mainland China.
The event, held at an air base in the southern Taiwanese city of Chiayi, saw the island commission the first combat wing of F-16 fighters, developed with US support.
The F-16 upgrades, costing T$110 billion (USD$3.95 billion), have been jointly completed by American manufacturer Lockheed Martin Corp and Taiwan’s Aerospace Industrial Development Corp.
Taiwan’s leader, Tsai Ing-wen, touted the new F-16s as ensuring that the island’s defenses would be “even stronger” in the face of increased tensions with China.
In October, Beijing sent a record 150 warplanes into Taiwan’s air defense identification zone (ADIZ) in four straight days of incursions. Over the past year, China’s Air Force has increased military activity in and around Taiwan’s ADIZ, according to Taipei.
Despite Taipei claiming it does not want to provoke a confrontation with China, the island’s president pledged that it will “do whatever it takes to defend itself.”
China has rejected claims that it is provoking conflict in Taiwan, which it sees as an integral part of its country, accusing America of “inflating” the island separatist movement, firmly stating that “Taiwan independence” is a dead end and Beijing will “take all steps” to ensure the island remains under its control. In recent years, China has become increasingly assertive about reuniting its wealthy island neighbor with the mainland.
The successful F-16 development process has been seen by Taiwan as the latest visible sign of the military partnership between Washington, DC and Taipei. Back in 2019, America approved an $8 billion sale of F-16s to Taiwan, which would bring the total number of jets in the island’s fleet to 200.
During the event, the Taiwanese president praised America for remaining steadfast in its cooperation with the island despite opposition from China. “As long as we adhere to the values of democracy and freedom, there will be more like-minded countries standing on the same front with us,” Tsai said alongside US diplomat Sandra Oudkirk.
In 2019, after the US and Taiwan agreed to upgrade the F-16 fighter jets, then-Foreign Ministry spokesperson Geng Shuang threatened to sanction American firms unless the deal was halted. Beijing opposed the military partnership between Taipei and Washington, DC, arguing that the sale violated international law, harmed relations between the countries, and breached the One China policy, which America recognizes.
Think your friends would be interested? Share this story!
Australia’s government could be forced to spend tens of millions in payouts after receiving more than 10,000 compensation claims from people who suffered side effects and loss of income due to Covid-19 vaccines.
Under its no-fault indemnity scheme, eligible claimants can apply for compensation amounts between AU$5,000 (US$3,646) to AU$20,000 (US$14,585) to cover medical costs and lost wages as a result of being hospitalized after getting the shot. The scheme’s online portal is scheduled to be launched next month.
Official figures suggest, however, that over 10,000 people have already indicated their intention to make a claim since registration opened on the health department’s website in September. If each claim was approved, the government could face a bill of at least AU$50 million (US$36.46 million).
There were around 78,880 adverse events to Covid-related vaccination in Australia as of November 7, according to the Therapeutic Goods Administration, which regulates national health products. The majority of side effects were minor, including headaches, nausea, and arm soreness.
Only people who experienced a moderate to significant adverse reaction that resulted in a hospital stay of at least one night are eligible for coverage under the government’s scheme. Those seeking $20,000 or less have to provide proof their claims are vaccine-related – although there has been no information as yet on exactly what evidence would be acceptable.
“Adverse events, even though they happen to a tiny proportion of people, for the people it does impact it’s really quite devastating,” Clare Eves, the head of medical negligence at injury compensation firm Shine Lawyers, told the Sydney Morning Herald.
Among the adverse reactions covered are the blood clotting disorder “thrombosis with thrombocytopenia syndrome (TTS)” linked to the AstraZeneca vaccine and the “myocarditis and pericarditis” heart conditions associated with the Pfizer vaccine. Other reportedly accepted side effects are Guillain-Barré syndrome, a rare neurological condition, and immune thrombocytopenia (excessive bleeding due to low platelet levels).
Claims for over $20,000, including those for vaccine-related deaths, will be assessed by an independent legal panel of legal experts and compensation paid on its recommendations. Nine people have reportedly died after an adverse reaction to one of the three vaccines in the country.
Eves told the Morning Herald that her firm was representing a number of litigants over the vaccine side effects, including several who are not eligible for the scheme.
